...PIK3CA and CDK6 mutations.,Further investigation on AZD6482 profile revealed that mutations in RB1, KRAS, NRAS and APC c...
...PIK3CA gene activating mutations, with an overall frequency of 20-40%. The aims of our study were to investigate PIK3CA ...
...PIK3CA and KRAS mutations.,We observed good similarity between primary tumors and the corresponding xenografts, at histo...
...PIK3CA mutation and resistance to mTOR inhibitors and GSK126, a molecular‑targeted drug can inhibit proliferation of ARI...
...PIK3CA mutation status.,There was a statistically significant interaction between post-diagnosis physical activity and t...
...PIK3CA, CBFB and PKHD1L1).,LCIS and ILC have a similar repertoire of somatic mutations, with PIK3CA and CDH1 being the m...
...PIK3CA are two direct targets of miR-203. Furthermore, we detected a lower p-IκBα and p-p65 level in the bronchial/trach...
...PIK3CA gene or loss of function of PTEN, a tumor suppressor protein, to name a few; both playing a crucial role in regul...
...PIK3CA, Akt1, Akt2, PTEN) were identified as being associated with chemotherapeutic response in 259 patients with stage ...
...PIK3CA were not detected. A loss of MUC5AC expression and mutations in KRAS and GNAS are key elements in the diagnosis o...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
